fenofibrate has been researched along with Anasarca in 5 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate did not inhibit mechanical allodynia or paw edema induced by phorbol-12,13-didecanoate (PDD), a protein kinase C activator, in rats." | 5.34 | Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma. ( Bertollo, CM; Coelho, MM; Costa, KA; Nascimento, EB; Oliveira, AC; Rocha, LT, 2007) |
| "Peroxisome proliferator-activated receptor (PPAR)-gamma ligand, pioglitazone (PIO), is reported to induce edema especially in postmenopausal women." | 3.74 | Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats. ( Hasegawa, K; Hayashi, K; Homma, K; Ito, O; Kanda, T; Omata, K; Saruta, T; Sugano, N; Tatematsu, S; Wakino, S; Yoshioka, K, 2008) |
| "Fenofibrate did not inhibit mechanical allodynia or paw edema induced by phorbol-12,13-didecanoate (PDD), a protein kinase C activator, in rats." | 1.34 | Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma. ( Bertollo, CM; Coelho, MM; Costa, KA; Nascimento, EB; Oliveira, AC; Rocha, LT, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prasad, GS | 1 |
| Govardhan, P | 1 |
| Deepika, G | 1 |
| Vakdevi, V | 1 |
| Sashidhar, RB | 1 |
| Oliveira, AC | 1 |
| Bertollo, CM | 1 |
| Rocha, LT | 1 |
| Nascimento, EB | 1 |
| Costa, KA | 1 |
| Coelho, MM | 1 |
| Stroup, JS | 1 |
| Karalliedde, J | 1 |
| Viberti, GC | 1 |
| Yoshioka, K | 1 |
| Wakino, S | 1 |
| Homma, K | 1 |
| Kanda, T | 1 |
| Tatematsu, S | 1 |
| Hasegawa, K | 1 |
| Sugano, N | 1 |
| Ito, O | 1 |
| Omata, K | 1 |
| Saruta, T | 1 |
| Hayashi, K | 1 |
5 other studies available for fenofibrate and Anasarca
| Article | Year |
|---|---|
Anti-inflammatory activity of anti-hyperlipidemic drug, fenofibrate, and its phase-I metabolite fenofibric acid: in silico, in vitro, and in vivo studies.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Computer Simulation; Cyclooxygenase 1; Cyclooxygenas | 2018 |
Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Disease Models, Animal; Dose-Response Re | 2007 |
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Fenofibrate; Humans; Hypoglycemic Agent | 2007 |
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Fenofibrate; Humans; Hypoglycemic Agent | 2007 |
Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.
Topics: Animals; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dinoprostone; Disease Models, Anima | 2008 |